Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-24 @ 9:16 PM
NCT ID:
NCT02555904
Eligibility Criteria:
Inclusion Criteria:
* • \> 18 years
* Prior diagnosis of heart failure with daily use of loop diuretic
* Must be identified within 48 hrs of admission
* Diagnosis of acute Congestive Heart Failure (CHF) as defined by at least one symptom or one clinical sign
* Believed to be \> 10 lbs above target weight
* Anticipated need for iv loop diuretic for at least 48 hrs
Exclusion Criteria:
* Inability to perform VA
* Respiratory infection
* Significant pulmonary disease requiring the use of inhaler bronchodilators or steroids
* Anticipate need for vasoactive agent or ultrafiltration
* Systolic BP \< 90 mmHg
* Serum Cr \> 3 on admission or requirement for dialysis
* Hemodynamically significant arrhythmias
* Acute Coronary Syndrome (ACS) within 4 weeks
* Hypertrophic Obstructive Cardiomyopathy (HOCM)
* Severe stenotic valve disease
* Complex congenital heart disease
* Sepsis
* Active smoking within 1 year
* O2 saturation less than 92% on room air
* History of diagnosed vocal cord pathology / dysfunction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02555904
Study Brief:
Protocol Section:
NCT02555904